Can taking pepcid limit alcohol flushing?

$905
Pledged
3%
Funded
$32,000
Goal
14
Days Left
  • $905
    pledged
  • 3%
    funded
  • 14
    days left

About This Project

The holiday season is here, bringing festive cheers and raising glasses of alcohol! For people who flush after drinking alcohol, they may take pills, probiotics, or patches to reduce alcohol flushing. However, do these treatments work?

Surprisingly, no one has scientifically tested whether treatments used for alcohol flushing are effective!

Here will tackle this question by determining if pepcid, a popular alcohol flushing remedy used on social media, stops alcohol flushing.

Ask the Scientists

Join The Discussion

What is the context of this research?

Imagine you’re out with friends, enjoying a drink, and suddenly your face turns bright red. This is called alcohol flushing, and it happens to about 1 in 10 people in the world [1], [2]. The red flush is caused by a genetic variant in an enzyme called ALDH2, which plays a key role in breaking down alcohol. When this enzyme doesn’t work properly, a toxic substance called acetaldehyde builds up, causing the redness, nausea, and increased heart rate[3], [4].

But here’s where it gets interesting: some people have posted on social media that pepcid, an over-the-counter heartburn medicine, may reduce alcohol-induced flushing. While it’s not intended for this use, pepcid might be altering how the body responds to alcohol in ways we don’t yet fully understand.

What is the significance of this project?

Understanding if pepcid works to reduce alcohol flushing could give us new insights into how our bodies handle alcohol. Additionally, studying this could uncover new treatments or health tips for people with ALDH2 deficiency, which may reduce not only discomfort but also the long-term health risks that are caused by alcohol drinking such as cancer and cardiovascular disease.

Plus, this research could reveal surprising new uses for a common drug that many people already have in their medicine cabinet!

By exploring how pepcid impacts alcohol metabolism, we could unlock critical information about a genetic condition affecting millions—and maybe even make social situations a little more comfortable for those who flush :)

What are the goals of the project?

The goal of this project is to uncover if pepcid can reduce alcohol flushing. To do so, we are going to conduct a human volunteer clinical trial and using cutting-edge technology to rigorously determine whether pepcid reduces alcohol flushing. We will use a cross-over approach to this clinical trial where a person will be tested in our laboratory twice. One time they will drink an exact amount of alcohol with a placebo and the other time they will drink an exact amount of alcohol with pepcid. Before and after they drink alcohol, we will measure breath acetaldehyde and alcohol in addition to heart rate, blood pressure, and skin temperature. Using this approach, we will determine whether pepcid changes the response to alcohol.

Budget

Please wait...

Our team is performing a clinical trial to determine whether pepcid decreases facial flushing, heart rate, and acetaldehyde levels after alcohol consumption. A clinical trial costs money and the science we are doing is rigorous. We are measuring alcohol and acetaldehyde in the breath after people drink alcohol with and without pepcid using cutting-edge mass spectrometry. We will also capture heart rate, blood pressure, and skin temperature before and after drinking alcohol with and without pepcid to determine if pepcid makes a difference. In this scientific way, we will be able to determine whether pepcid is effective in reducing alcohol flushing!

Endorsed by

As an individual with a family history of alcohol flushing and a researcher specializing in ALDH2 deficiency, I deeply appreciate the potential of this research for the large population affected by this genetic condition. This project addresses a common but underrecognized issue impacting millions, posing serious alcohol-related health risks, especially during family gatherings. Eric and his talented team, with a strong research background, are conducting important work that could significantly improve health and quality of life.
I'm excited about this project because Dr. Eric Gross is an experienced researcher in this field who will advance our understanding of how genetic variants in ALDH2 affect acetaldehyde metabolism, and their impact on human health when consuming alcohol.
Whether we experience it ourselves or know of friends and loved ones who do, alcohol flushing affects all of us. Dr. Gross and his superstar team are experts on this topic and have published important research on the long-term health impacts of alcohol intolerance. Their work has educated me and so many people I know on the consequences of alcohol flushing, and I am excited for their work to continue through yet another important mission: investigating real data and science about a remedy we need to understand better!

Project Timeline

January 2025- May 2025: Write and get approved the Institutional Review Board (IRB) protocol for this study. Enroll the study in clinicaltrials.gov

May 2025- August 2025: Recruit up to 12 people for the cross-over study. We plan to have 6 people who do not flush after they drink alcohol and 6 people who flush. Equal number of males and females.

September 2025 - November 2025: Analyze the results of the study and write-up a report to share.

Nov 20, 2024

Project Launched

Apr 30, 2025

Obtain IRB approval to conduct the study

May 31, 2025

Recruit first cohort of people for the study

Oct 01, 2025

Complete analysis of study results

Oct 29, 2025

Write-up a report and send the results and a video to backers of the project

Meet the Team

Eric Gross
Eric Gross
Associate Professor

Affiliates

School of Medicine, Stanford University
View Profile

Team Bio

We have a multidisciplinary team that will help with this question. Our team is dedicated to studying the health risks associated with alcohol intolerance. Our goal is to come up with solutions to reduce the health risks of cardiovascular disease and cancer that are associated with alcohol intolerance.

Eric Gross

I am an Associate Professor at Stanford University who studies the health impact of alcohol intolerance. Intolerance to alcohol causes facial flushing and increased heart rate when alcohol is consumed. This is due to the accumulation of an alcohol metabolite acetaldehyde. Nearly 540 million people in the world have alcohol intolerance.

A number of strategies are on the market to treat alcohol flushing after alcohol consumption. However, none of these strategies have been rigorously tested in people to see if they are effective in reducing alcohol flushing. With your support, let's test these strategies used to treat alcohol flushing scientifically to see if any of these are effective!

https://ericgrosslab.stanford....

Lab Notes

Nothing posted yet.

Additional Information

We have the capabilities and techniques to perform these studies in a scientifically rigorous manner. Our techniques we will use are scientifically published in the Journal of Translational Medicine (https://translational-medicine...).

Our goal is to start with testing how pepcid impacts the response to alcohol and as a next step we plan to test other commonly used treatment strategies such as probiotics and patches to scientifically determine if these treatments are effective at reducing alcohol flushing.


Project Backers

  • 4Backers
  • 3%Funded
  • $905Total Donations
  • $226.25Average Donation
Please wait...

See Your Scientific Impact

You can help a unique discovery by joining 4 other backers.
Fund This Project